Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease

American Journal of Gastroenterology

Volumn 95, Issue 6, 2000, Pages 1495-1502

  Caradonna, L ^a   Amati, L ^a   Lella, P ^a   Jirillo, E ^c   Caccavo, D ^b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENDOTOXIN; LACTOFERRIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MUCOSAL IMMUNITY; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA TYPHI; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; BLOOD BACTERICIDAL ACTIVITY; CELL DEATH; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTOFERRIN; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0034122116     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00877-7     Document Type: Article

References (38)

1. Mac Dermott R.P. Alteration of the mucosal immune system in inflammatory bowel disease. J Gastroenterol. 31:1996;905-916.
2. Amati L., Caradonna L., Jirillo E., et al. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital J Gastroenterol Hepatol. 31:1999;313-325.
3. 2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 101:1995;28-35.
4. Sartor R.B. Cytokines in intestinal inflammation Pathophysiological and clinical considerations . Gastroenterology. 106:1994;533-539.
5. Liu Y., Van Kruningen H.J., West A.B., et al. Immunocytochemical evidence of Listeria, Escherichia Coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 108:1995;1396-1404.
6. Saxon A., Shanahan F., Landers C.J., et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 86:1990;202-210.
7. Cambridge G., Rampton D.S., Stevens R.J., et al. Anti-neutrophil antibodies in inflammatory bowel disease. Prevalence and diagnostic role. Gut. 33:1992;668-674.
8. Saverymuttu S.H., Peters A.M., Lavender J.P., et al. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease. Gut. 26:1985;378-383.
9. m technetium phagocyte scanning. Gastroenterology. 95:1988;989-996.
10. Liu Z.X., Hiwatashi N., Noguchi M., et al. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand J Gastroenterol. 32:1997;1241-1246.
11. Matsura T., West G.A. Klein JS. Soluble interleukin-2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology. 102:1992;2006-2014.
12. Balzano A., Bove A., Leonardi E., et al. The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 9:1997;173-177.
13. Falk J.R., Terrel R.S., Charles L.A., et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate, and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 87:1990;4115-4119.
14. Mulder A.H.L., Heeringa P., Brower E., et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) A Fc γRII-dependent process . Clin Exp Immunol. 98:1994;270-278.
15. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis. Br Med J. 2:1955;1041-1048.
16. Best W.R., Becktel J.M., Singleton J.W., et al. Development of a Crohn's disease activity index. Gastroenterology. 70:1976;439-444.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 21:(suppl 97):1968;77-89.
18. Kumagai K., Itoh K., Hinuma S., et al. Pretreatment of plastic Petri dishes with foetal calf serum. A simple method for macrophage isolation. J Immunol Meth. 29:1979;17-25.
19. Mandell L., Hook W.E. Leukocyte function in chronic granulomatous diseases of childhood. Am J Med. 47:1969;473-478.
20. Antonaci S., Tortorella C., De Simone C., et al. Role of bacterial lipopolysaccharides in the development of natural antibacterial activity mediated by human peripheral blood T lymphocytes. Int Rev Immunol. 6:1990;237-245.
21. Tagliabue A., Villa Boraschi D., et al. Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol. 135:1985;4178-4182.
22. Afeltra A., Sebastiani G.D., Galeazzi M., et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol. 23:1996;10-15.
23. Sartor R.B. Cytokines in inflammatory bowel disease. Prog Inflammatory Bowel Dis. 12:1991;5-8.
24. Amati L., Caradonna L., Greco B., et al. Impairment of cellular immune responsiveness in relatives of patients affected by ulcerative colitis. Gastroenterology. 114:1998;AG3769.
25. Jirillo E., Amati L., Caradonna L., et al. Soluble (s) CD14, and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before, and after treatment with interferon-α Immunopharmacol Immunotoxicol. 20:1998;1-14.
26. Amati L., Caradonna L., Greco B., et al. Impairment of phagocytic and T-cell mediated antibacterial activity and plasmatic endotoxin in patients with untreated gastrointestinal cancer. Scand J Gastroenterol. 33:1998;847-852.
27. Wellmann W., Fink P.C., Benner F., et al. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 27:1986;814-820.
28. Waage C.S., Brandzaeg P., Halstensen A., et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med. 169:1989;333-338.
29. Isaacs K.L., Sartor R.B., Haeskil J.S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology. 103:1992;1587-1595.
30. Mac Donald T.T., Hutchings P., Choy M.-Y., et al. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 81:1990;1301-1307.
31. Murch S.H., Braegger C.P., Walker-Smith J.A., et al. Location of tumor necrosis factor-alpha by immunohistochemistry in cronic inflammatory bowel disease. Gut. 34:1993;1705-1712.
32. Braegger C.P., Nicholls S., Murch S.M., et al. Tumor necrosis factor-alpha in stool as a marker of intestinal inflammation. Lancet. 339:1992;89-91.
33. Peen E., Almer S., Bodemar G., et al. Anti-lactoferrin antibodies, and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut. 34:1993;56-62.
34. Kossa K., Coulthart A., Ives C.T., et al. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 7:1995;783-789.
35. Stoffel M.P., Csernok E., Gross W.L. Target antigen for anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Scand J Gastroenterol. 31:1996;943-944.
36. Appelmelk B.J., An Y.Q., Geerts M., et al. Lactoferrin is a lipid A-binding protein. Infect Immun. 62:1994;2628-2632.
37. Caccavo D., Afeltra A., Pece S., et al. Lactoferrin-lipid A-lipopolysaccharide interaction. Inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14. Infect Immun. 67:1999;4668-4672.
38. Elass-Rochard E., Legrand D., Salmon V., et al. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun. 66:1998;486-491.